Wu Shaoguang, Dreyfus Lawrence A, Tzianabos Art O, Hayashi Chika, Sears Cynthia L
Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Infect Immun. 2002 May;70(5):2463-71. doi: 10.1128/IAI.70.5.2463-2471.2002.
Enterotoxigenic Bacteroides fragilis (ETBF) strains produce a 20-kDa zinc metalloprotease toxin (BFT) associated with diarrheal disease of animals, young children, and adults. BFT stimulates secretion in intestinal loops in vivo and modifies epithelial cell morphology in vitro. The B. fragilis toxin (bft) gene from ETBF strain 86-5443-2-2 (piglet; bft-2) revealed significant nucleotide and predicted amino acid differences when compared to the bft gene from ETBF strain VPI 13784 (lamb; bft-1). This study compares BFT-1 and BFT-2, respectively, produced by ETBF strains VPI 13784 and 86-5443-2-2 purified using the Van Tassell method (38) and a modified purification scheme described herein. Multiple differences in the protein toxins produced by these ETBF strains were identified. First, purified BFT-1 eluted from a high-resolution anion-exchange column (Mono Q) at 0.22 +/- 0.005 M NaC1 versus 0.18 +/- 0.001 M NaC1 for BFT-2 (P < 0.001). Second, BFT-1 and BFT-2 exhibited different electrophoretic mobilities on sodium dodecyl sulfate-polyacrylamide gel electrophoresis and reverse-phase fast protein liquid chromatography. Third, each BFT reacted with greater specificity to homologous rather than heterologous antisera. Fourth, BFT-2 had modest, but consistently, greater biological activity than BFT-1 when tested on HT29/C1 cells (P < or = 0.01). Together, these data indicate that these ETBF strains produce two distinct isotypes of BFT, termed BFT-1 (VPI 13784 BFT) and BFT-2 (86-5443-2-2 BFT) to recognize the order in which the proteins were purified and genetic sequences identified. The modified purification scheme described in this report yields about two to three times more purified BFT protein than previous protocols and is less time consuming.
产肠毒素脆弱拟杆菌(ETBF)菌株产生一种20 kDa的锌金属蛋白酶毒素(BFT),与动物、幼儿及成人的腹泻病有关。BFT在体内可刺激肠袢分泌,在体外可改变上皮细胞形态。与ETBF菌株VPI 13784(羔羊;bft-1)的bft基因相比,ETBF菌株86-5443-2-2(仔猪;bft-2)的脆弱拟杆菌毒素(bft)基因在核苷酸和预测的氨基酸方面存在显著差异。本研究分别比较了ETBF菌株VPI 13784和86-5443-2-2产生的BFT-1和BFT-2,这两种毒素分别采用Van Tassell方法(38)和本文所述的改良纯化方案进行纯化。已确定这些ETBF菌株产生的蛋白质毒素存在多个差异。首先,从高分辨率阴离子交换柱(Mono Q)上洗脱的纯化BFT-1的氯化钠浓度为0.22±0.005 M,而BFT-2为0.18±0.001 M(P<0.001)。其次,BFT-1和BFT-2在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳和反相快速蛋白质液相色谱上表现出不同的电泳迁移率。第三,每种BFT与同源抗血清的反应特异性高于异源抗血清。第四,在HT29/C1细胞上进行测试时,BFT-2的生物学活性比BFT-1适度但始终更高(P≤0.01)。这些数据共同表明,这些ETBF菌株产生两种不同的BFT同种型,分别称为BFT-1(VPI 13784 BFT)和BFT-2(86-5443-2-2 BFT),以识别蛋白质纯化的顺序和鉴定的基因序列。本报告中描述的改良纯化方案产生的纯化BFT蛋白比以前的方案多约两到三倍,且耗时更短。